Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024
Compare Balance Sheet Results of Asston Pharmaceu
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.27
3.09
3.18
102.91%
Share Warrants & Outstandings
Total Reserve
4.76
68.71
-63.95
-93.07%
Shareholder's Funds
11.04
71.80
-60.76
-84.62%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.26
0.00
2.26
0.00%
Secured Loans
0.80
0.00
0.80
0.00%
Unsecured Loans
1.45
0.00
1.45
0.00%
Deferred Tax Assets / Liabilities
-0.02
0.11
-0.13
-118.18%
Other Long Term Liabilities
0.16
0.00
0.16
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.39
0.11
2.28
2,072.73%
Current Liabilities
Trade Payables
5.97
38.70
-32.73
-84.57%
Other Current Liabilities
3.70
0.94
2.76
293.62%
Short Term Borrowings
5.00
9.91
-4.91
-49.55%
Short Term Provisions
0.00
0.02
-0.02
-100.00%
Total Current Liabilities
14.67
49.58
-34.91
-70.41%
Total Liabilities
28.10
121.49
-93.39
-76.87%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.10
16.85
-15.75
-93.47%
Less: Accumulated Depreciation
0.14
6.37
-6.23
-97.80%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.96
10.48
-9.52
-90.84%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
3.44
-3.44
-100.00%
Long Term Loans & Advances
0.00
0.75
-0.75
-100.00%
Other Non Current Assets
0.00
3.46
-3.46
-100.00%
Total Non-Current Assets
0.96
18.13
-17.17
-94.70%
Current Assets Loans & Advances
Current Investments
0.00
0.36
-0.36
-100.00%
Inventories
0.72
38.01
-37.29
-98.11%
Sundry Debtors
24.55
56.54
-31.99
-56.58%
Cash and Bank
0.20
0.16
0.04
25.00%
Other Current Assets
0.14
0.17
-0.03
-17.65%
Short Term Loans and Advances
1.55
8.13
-6.58
-80.93%
Total Current Assets
27.15
103.36
-76.21
-73.73%
Net Current Assets (Including Current Investments)
12.47
53.78
-41.31
-76.81%
Total Current Assets Excluding Current Investments
27.15
103.00
-75.85
-73.64%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.10
121.49
-93.39
-76.87%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.26
9.91
-2.65
-26.74%
Book Value per share (adjusted)
17.60
232.39
-214.79
-92.43%
Annual - Borrowings
Borrowings 7.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 27.15 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024






